首页/数据集/Mamet et al, 2017 - Toxicological Sciences - 05 25 17 -Supplemental Table 3

Mamet et al, 2017 - Toxicological Sciences - 05 25 17 -Supplemental Table 3

Dryad2017-01-01 更新2026-04-13 收录

毒理学临床病理

药物安全性评估

数据链接：

http://datadryad.org/resource/doi:10.5061/dryad.dh250/4 数据链接链接失效反馈

官方服务：

资源简介：

Clinical laboratory assessments of female rats at Day 3 and 30 in the ADY-TX2 study

应用场景：

创建时间：

2017-01-01

新生儿抗真菌预防

药物安全性评估

Prior and Concomitant Medications and Systemic Antimicrobials Dataset Study Description This was a prospective, randomized, double-blind, multi-center, efficacy study comparing fluconazole prophylaxis

NIAID Data Ecosystem50

Local and Solicited Systemic Reactogenicity.

疫苗反应原性

药物安全性评估

Local and Solicited Systemic Reactogenicity.

NIAID Data Ecosystem40

药物安全性评估

临床试验不良事件

Treatment-related AEs of all grades reported by ≥10% of patients in either cohort (safety population) and treatment-related AEs of grade 3 and 4.

NIAID Data Ecosystem30

Checklist S1 - Increased Risk of High-Grade Hemorrhage in Cancer Patients Treated with Gemcitabine: A Meta-Analysis of 20 Randomized Controlled Trials

药物安全性评估

治疗并发症

PRISMA Checklist. (DOC)

Figshare2015-12-02 更新40

Subgroup analysis of the association between PPI therapy and significant small-bowel lesions in users and non-users of nonsteroidal anti-inflammatory drugs.

药物安全性评估

胃肠道病变关联分析

Subgroup analysis of the association between PPI therapy and significant small-bowel lesions in users and non-users of nonsteroidal anti-inflammatory drugs.

NIAID Data Ecosystem40

Mamet et al, 2017 - Toxicological Sciences - 05 25 17 -Supplemental Table 3

资源简介：

相关数据集